An Open-Label Single-Dose And Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study To Evaluate The Efficacy, Safety, Tolerability, And Pharmacokinetics Of Oxymorphone Hydrochloride (HCl) For Acute Moderate To Severe Postoperative Pain In Pediatric Subjects
Phase of Trial: Phase III
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Oxymorphone (Primary) ; Oxymorphone (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 17 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2020.
- 22 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Feb 2016 New trial record